A recent study has established that pretreatment of human mesenchymal stem/stromal cells (MSC) with GHK presented in a biodegradable carrier (alginate gel) produced a dose-dependent increase in secretion of proangiogenic factors such as the vascular endothelial growth factor (VEGF) and basic fibroblast growth factor
J Biol Chem 1998;273:329337
Researchers theorize that asthma may be due to either inappropriate mast cell activation or that the mast cells are hypersecretory.[ref][ref] One study sums up that mast cells release preformed mediators including chymase, tryptase, and histamine and de novo synthesized mediators such as PGD2, LTC4, and LTE4 in addition of cytokines mainly TGF1, TSLP, IL-33, IL-4, and IL-13 participate in the pathogenesis of asthma.[ref] Related article : Asthma: understanding the genetics and underlying causes Osteoarthritis: Mast cells as a causative factor Osteoarthritis, the most common form of arthritis, is caused by inflammation and degeneration of the joint tissue
James SJ, Cutler P, Melnyk S, Jernigan S, Janak L, Gaylor DW, Neubrander JA (2004) Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism
More than 27 billion doses of acetaminophen-containing products were sold in the U.S